“The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients”. Jurnal Respirologi Indonesia, vol. 42, no. 4, Sept. 2022, pp. 277–281, https://doi.org/10.36497/jri.v42i4.370.